Valuation: LeMaitre Vascular, Inc.

Market Cap 2.19B 1.93B 1.77B 1.65B 3.11B 208B 3.18B 21.31B 8.26B 102B 8.23B 8.06B 356B P/E 2026 *
32x
P/E 2027 * 29.5x
Enterprise Value 1.94B 1.7B 1.57B 1.46B 2.76B 185B 2.81B 18.87B 7.31B 90.61B 7.29B 7.13B 315B EV / Sales 2026 *
6.93x
EV / Sales 2027 * 6.14x
Free-Float
87.27%
Yield 2026 *
1.04%
Yield 2027 * 1.17%
1 day+3.87%
1 week+3.73%
Current month-0.60%
1 month+3.09%
3 months-11.17%
6 months+21.90%
Current year+19.29%
1 week 80.5
Extreme 80.5
84
1 month 75.5
Extreme 75.5
84
Current year 68
Extreme 68
99
1 year 67.5
Extreme 67.5
99
3 years 42
Extreme 42
102
5 years 35.4
Extreme 35.4
102
10 years 19.1
Extreme 19.1
102
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Change 5-day change 1-year change 3-year change Capi.($)
+3.87%+3.73% - - 2.19B
+2.64%+4.09%+21.55%-1.31% 186B
+0.93%-0.22%-25.47%+19.32% 141B
+1.88%+2.22%-4.00%-18.47% 135B
+0.86%-3.59%-59.09%-19.94% 63.44B
+1.92%+2.86%+19.49%+0.80% 52.09B
+0.82%+0.73%-26.51%-31.97% 43.6B
+0.94%+1.65%+11.09%+12.14% 37.52B
+1.23%+2.56%+6.04%+43.00% 36.82B
+1.00%-0.49%-15.00%-19.99% 29.12B
Average +1.60%+2.57%-7.99%-1.82% 80.51B
Weighted average by Cap. +1.64%+3.86%-5.24%-1.62%

Financials

2026 *2027 *
Net sales 280M 246M 226M 211M 398M 26.62B 406M 2.72B 1.05B 13.07B 1.05B 1.03B 45.47B 306M 268M 247M 230M 434M 29.07B 443M 2.97B 1.15B 14.27B 1.15B 1.12B 49.66B
Net income 69.28M 60.83M 55.99M 52.17M 98.39M 6.59B 100M 673M 261M 3.23B 260M 254M 11.25B 75.98M 66.71M 61.4M 57.22M 108M 7.22B 110M 739M 286M 3.55B 285M 279M 12.34B
Net Debt -251M -221M -203M -189M -357M -23.88B -364M -2.44B -946M -11.72B -943M -923M -40.8B -314M -276M -254M -237M -446M -29.86B -455M -3.05B -1.18B -14.66B -1.18B -1.15B -51.01B
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change
26-07-01 83.50 -0.60%
26-06-30 €84.00 0.00%
26-06-29 €84.00 +2.44%
26-06-26 €82.00 +1.86%
26-06-25 €80.50 0.00%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
95.96USD
Average target price
118.75USD
Spread / Average Target
+23.75%

Quarterly revenue - Rate of surprise